PHARMACY wholesaler, Sigma Healthcare, saw its shareprice slump by more than 9% during yesterday's trading, after rival Australian Pharmaceutical Industries (API) announced it had divested its interest in the company.
The stock sell-off followed last year's aborted merger between the two groups, and wiped out gains made on Fri, in the wake of Sigma's market update, forecasting accelerated growth for the 2021 financial year, following its agreement to become My Chemist/Chemist Warehouse's first line supplier of fast moving consumer goods (PD 16 Dec).
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Dec 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Dec 19
